Hans Hull - Insider Trading & Ownership

Entity
Individual
Location
C/O Avalanche Biotechnologies, Inc., 1035 O'brien Drive, Suite A, Menlo Park, CA
Summary
The estimated net worth of Hans Hull is at least $2.86M dollars as of July 12, 2024. Hans Hull is the Chief Business Officer of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $2.86M.
All Insider Reports
All Insider Reports

Ownership of Hans Hull

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PLRX PLIANT THERAPEUTICS, INC. Chief Business Officer $2.86M -$283K -9.02% Jul 10, 2024

Insider Transactions Reported by Hans Hull:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.